Effects of Comorbidities on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasms

The CACI can be used to identify patients with a high risk of death from factors other than IPMNs within a few years after diagnosis. These patients are therefore not likely to benefit from further IPMN observation or pancreatic resection.